AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 23- Open
- $835.74
- 52-wk high
- $847.00
- High
- $847.00
- 52-wk low
- $538.24
- Low
- $826.64
- Prev close
- $826.64
Smart money
Earnings
Earnings came in 56.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $3.75B | $3.88B | $3.61B | $4.29B |
| Cost of what it sold | $521.6M | $584.6M | $669.4M | $576.5M |
| Gross profit | $3.23B | $3.30B | $2.94B | $3.71B |
| What it spent | ||||
| Research and development | $1.56B | $1.63B | $1.65B | $1.63B |
| Sales and admin | $657.8M | $775.0M | $647.7M | $662.1M |
| Total operating expenses | $2.21B | $2.42B | $2.29B | $2.29B |
| What was left | ||||
| Operating profit | $1.03B | $879.9M | $642.9M | $1.42B |
| Interest on debt | $19.3M | $12.2M | $12.9M | $11.0M |
| Profit before tax | $1.76B | $1.04B | $831.2M | $1.53B |
| Tax | $303.3M | $199.1M | $104.0M | $230.9M |
| Net profit | $1.46B | $844.6M | $727.2M | $1.30B |
| EBITDA | $1.92B | $1.20B | $967.3M | $1.66B |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
79overbought
20D volatility
31%annualized
52-week range
$538.24$847.00
20D support
News
What the news says
50 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Wealthfront Advisers LLC Invests $4.37 Million in Regeneron Pharmaceuticals, Inc. $REGN
Leans bullishAug 21Ceredex Value Advisors LLC Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN
NeutralAug 21Telix advances radiopharmaceutical pipeline as H1 revenue reaches $477 million
Leans bullishAug 21
